Patents Assigned to Klomed Pharma
  • Patent number: 9901543
    Abstract: The invention relates to a thermogelling composition comprising a chitosan having N-acetyl-glucosamine units, glucosamine units, and substituted glucosamine units other than the N-acetyl-glucosamine units, said substituted chitosan preferably having a degree of substitution of the glucosamine units ranging from 10 to 50%, expressed as a number of moles of the substituent based on the number of moles of total units, to its preparation and to its applications.
    Type: Grant
    Filed: January 31, 2017
    Date of Patent: February 27, 2018
    Assignee: Klomed Pharma
    Inventors: Mickaƫl Chausson, Renaud Lecler